Drug company (FDA labeler)
UBI Pharma Inc.
NDC labeler code: 72843
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Desmopressin acetateDdavp, Stimate, Desmoda · 3 products
- VoriconazoleVfend · 1 product
- OlanzapineZyprexa, Zyprexa Zydis, Olanzapine Intramuscular · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| June 11, 2025 | ANDA211072 | Olanzapine OLANZAPINE | Ubi |
| March 9, 2023 | ANDA211264 | Voriconazole VORICONAZOLE | Ubi |
| September 17, 2020 | ANDA210223 | Desmopressin acetate DESMOPRESSIN ACETATE | Ubi |
| February 14, 2020 | ANDA210218 | Desmopressin acetate DESMOPRESSIN ACETATE | Ubi |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026